Mastrad (ALMAS) fair value: what the stock is really worth
We calculate from audited financials what Mastrad is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Valuation from Sep 13, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
Watch Mastrad for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
60‑month range €0.0016 – €0.7440 · the €0.0040 price screens below the €0.0043 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.
Follow Mastrad in your weekly email
Every Wednesday you see whether Mastrad is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Mastrad designs, distributes, and sells cooking accessories in France and the Americas. The company offers cooking thermometers under the ORKA brand; and maryse spatulas, pastry molds, whippers, and minute cookers. Mastrad was incorporated in 1994 and is headquartered in Paris, France.
Stock analysis
Mastrad (ALMAS) currently trades at €0.0040, while our model-based Fair Value estimate is €0.0043, implying the stock looks roughly 7.4% fairly valued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 95/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 20/100 (below-average quality), in the Consumer Defensive sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Mastrad reported revenue of €489K in FY2025 versus €9.5M in FY2021, a compound −52.4%/yr. Reported net income was −€1.6M in FY2025.
Key figures
Market cap €611K · P/S ratio 0.82 · EPS (TTM) €−0.0200 · Return on equity −678% · Return on assets (EBIT) −21.0% · Operating margin −336% · Revenue (TTM) €745K · Revenue growth (YoY) −10.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 70% below its 52-week high and 150% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −14% fair-value upside, at 8%, ALMAS screens cheaper than that median.
Notify me when ALMAS reaches fair value
Put ALMAS on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−73.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−58.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−37.3%
Start year 2020 (pandemic). Over 10 years: −31.2% a year
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−25.1% (2020) → −334.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 251 stocks
Beats the industry median on 1/6 measures
Overall it trails its industry peers.
Valuation
Quality Score16 · Bottom 25%
Fair Value upside−4% · Below median
Profitability
Return on assets−40% · Bottom 25%
Growth and dividend
Revenue growth−10% · Bottom 25%
Balance sheet
Debt / equity1.99× · Highest 25%
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
P/B1.20× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Mastrad Fair Value". https://www.fairvalue-calculator.com/stock/ALMAS
Frequently asked questions
Is Mastrad (ALMAS) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of €0.0043 versus a price of €0.0040, about +8% upside (fairly valued).
What is the fair value of ALMAS?
Our model-based fair value for Mastrad is €0.0043 (as of Sep 13, 2026), built from audited fundamentals. The current price: €0.0040.
What is the quality score of ALMAS?
Mastrad has a Quality Score of 20/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Mastrad (ALMAS)?
Our model-based price target is the fair value of €0.0043 (as of Sep 13, 2026) from 2 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Mastrad stock forecast for 2026?
Our models put fair value at €0.0043, about +8% upside versus a price of €0.0040 (fairly valued). The calculation is refreshed regularly with new filings.
What is the revenue of Mastrad (ALMAS)?
Mastrad reported trailing-twelve-month revenue of about €745K (latest available figure, as of Sep 13, 2026).
What is the intrinsic value of Mastrad (ALMAS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mastrad it is €0.0043 per share (as of Sep 13, 2026), against a price of €0.0040. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Mastrad stock overvalued or undervalued in 2026?
As of Sep 13, 2026, ALMAS trades below its calculated fair value: price €0.0040, fair value €0.0043, a gap of about +8% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALMAS?
No. The price is what the market pays today (€0.0040); the fair value is what the company's own numbers justify (€0.0043). For Mastrad the two are €0.0003 per share apart. That gap is exactly why we show both numbers side by side.
How much is Mastrad worth?
The market values Mastrad at about €611K (market capitalisation, as of Sep 13, 2026). Per share that is €0.0040; our models calculate a fair value of €0.0043 per share.
How solid is the balance sheet of Mastrad (ALMAS)?
Balance-sheet figures for Mastrad (as of Sep 13, 2026): debt of 1.99 per unit of equity. They feed the Quality Score of 20/100, which measures business quality independently of the share price.
How far is ALMAS from its 52-week high?
Mastrad trades at €0.0040, about 70% below its 52-week high of €0.0132 and 150% above the low of €0.0016 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of €0.0043 is for.
Which stocks are comparable to Mastrad?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, Kimberly-Clark Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Mastrad stock attractive at the current price?
The data as of Sep 13, 2026: price €0.0040, calculated fair value €0.0043 (+8%), Quality Score 20/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALMAS calculated?
We run Mastrad through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €0.0043, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Mastrad currently trades 8 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Mastrad (ALMAS)?
The closing price on Sep 24, 2026 was €0.0040. Our model-based fair value is €0.0043, about +8% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Mastrad right now?
The price is below even our cautious bear case (€0.0043). The market is more pessimistic than our downside scenario. The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Mastrad
How large is the market capitalisation of Mastrad (ALMAS)?
The market capitalisation of Mastrad is €611K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Mastrad (ALMAS)?
The price-to-sales ratio of Mastrad is 0.82 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Mastrad (ALMAS)?
Earnings per share at Mastrad are €−0.0200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Mastrad (ALMAS)?
The return on equity (ROE) of Mastrad is −678% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Mastrad (ALMAS)?
On an EBIT basis the return on assets of Mastrad is −21.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Mastrad (ALMAS)?
The operating margin of Mastrad is −336% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Mastrad (ALMAS)?
Revenue at Mastrad is growing −10.2% versus a year earlier (3y avg −58.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Mastrad (ALMAS) generate?
The free cash flow of Mastrad is −€73.0K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Mastrad (ALMAS) carry?
The net debt of Mastrad is €1.3M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Mastrad in the live analysis
One click puts Mastrad on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
